目次

Table of Content

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Type
1.1.3. End Use
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Healthcare Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Implementation of international standards by contract manufacturers
3.2.1.2. Drug shortage driving the demand for pharmaceutical development
3.2.1.3. Commercial success of biologics for clinical use
3.2.2. Market Restraint Analysis
3.2.2.1. Regulatory and legal compliance
3.2.2.2. Threat of information loss
3.2.3. Industry Challenges
3.2.3.1. Managing relationships
3.3. Healthcare Contract Manufacturing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Manufacturing Market: Type Segment Analysis
4.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
4.2 Medical Device
4.2.1 Medical device market, 2018 - 2030 (USD Million)
4.2.2 Service
4.2.2.1 Accessories manufacturing
4.2.2.1.1 Accessories manufacturing market, 2018 - 2030 (USD Million)
4.2.2.2 Assembly manufacturing
4.2.2.2.1 Assembly manufacturing market, 2018 - 2030 (USD Million)
4.2.2.3 Component manufacturing
4.2.2.3.1 Component manufacturing market, 2018 - 2030 (USD Million)
4.2.2.4 Device manufacturing
4.2.2.4.1 Device manufacturing market, 2018 - 2030 (USD Million)
4.2.3 Therapeutic area
4.2.3.1 Cardiology
4.2.3.1.1 Cardiology market, 2018 - 2030 (USD Million)
4.2.3.2 Diagnostic imaging
4.2.3.2.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
4.2.3.3 Orthopedic
4.2.3.3.1 Orthopedic market, 2018 - 2030 (USD Million)
4.2.3.4 IVD
4.2.3.4.1 IVD market, 2018 - 2030 (USD Million)
4.2.3.5 Ophthalmic
4.2.3.5.1 Ophthalmic market, 2018 - 2030 (USD Million)
4.2.3.6 General & plastic surgery
4.2.3.6.1 General & plastic surgery market, 2018 - 2030 (USD Million)
4.2.3.7 Drug delivery
4.2.3.7.1 Drug delivery market, 2018 - 2030 (USD Million)
4.2.3.8 Dental
4.2.3.8.1 Dental market, 2018 - 2030 (USD Million)
4.2.3.9 Endoscopy
4.2.3.9.1 Endoscopy market, 2018 - 2030 (USD Million)
4.2.3.10 Diabetes care
4.2.3.10.1 Diabetes care market, 2018 - 2030 (USD Million)
4.2.3.11 Others
4.2.3.11.1 Others market, 2018 - 2030 (USD Million)
4.3 Pharmaceutical
4.3.1 Pharmaceutical market, 2018 - 2030 (USD Million)
4.3.2 Service
4.3.2.1 API/bulk drugs
4.3.2.1.1 API/bulk drugs market, 2018 - 2030 (USD Million)
4.3.2.2 Advanced drug delivery formulations
4.3.2.2.1 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
4.3.2.3 Packaging
4.3.2.3.1 Packaging market, 2018 - 2030 (USD Million)
4.3.2.4 Finished dose formulations
4.3.2.4.1 Finished dose formulations market, 2018 - 2030 (USD Million)
4.3.2.4.2 Solid
4.3.2.4.2.1 Solid market, 2018 - 2030 (USD Million)
4.3.2.4.3 Liquid
4.3.2.4.3.1 Liquid market, 2018 - 2030 (USD Million)
4.3.2.4.4 Semisolid formulations
4.3.2.4.4.1 Semisolid formulations market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Contract Manufacturing Market: End Use Segment Analysis
5.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
5.2 Medical Device Companies
5.2.1 Medical device companies market, 2018 - 2030 (USD Million)
5.3 Pharmaceutical & Biopharmaceutical Companies
5.3.1 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
5.4 Others
5.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Contract Manufacturing Market: Regional Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Denmark
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
6.5.7. Sweden
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
6.5.8. Norway
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
6.5.9. Belgium
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Belgium Market Estimates and Forecasts, 2018 - 2030
6.5.10. Netherlands
6.5.10.1. Key Country Dynamics
6.5.10.2. Competitive Scenario
6.5.10.3. Regulatory Framework
6.5.10.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.6.7. Philippines
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Philippines Market Estimates and Forecasts, 2018 - 2030
6.6.8. Malaysia
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
6.6.9. New Zealand
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. New Zealand Market Estimates and Forecasts, 2018 - 2030
6.6.10. Singapore
6.6.10.1. Key Country Dynamics
6.6.10.2. Competitive Scenario
6.6.10.3. Regulatory Framework
6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.7.4. Colombia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
6.7.5. Chile
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
6.8. MEA
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Kuwait
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
6.8.5. Israel
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2022
7.2. Company Profiles
7.2.1 Nordson Corporation.
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Service benchmarking
7.2.1.4 Strategic initiatives
7.2.2 Integer Holdings Corporation
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Service benchmarking
7.2.2.4 Strategic initiatives
7.2.3 Jabil Inc.
7.2.3.1 Company overview
7.2.3.2 Financial performance
7.2.3.3 Service benchmarking
7.2.3.4 Strategic initiatives
7.2.4 Viant Technology LLC
7.2.4.1 Company overview
7.2.4.2 Service benchmarking
7.2.4.3 Strategic initiatives
7.2.5 FLEX LTD.
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Service benchmarking
7.2.5.4 Strategic initiatives
7.2.6 Celestica Inc.
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Service benchmarking
7.2.6.4 Strategic initiatives
7.2.7 Sanmina Corporation
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Service benchmarking
7.2.7.4 Strategic initiatives
7.2.8 Plexus Corp.
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Service benchmarking
7.2.8.4 Strategic initiatives
7.2.9 Phillips-Medisize
7.2.9.1 Company overview
7.2.9.2 Service benchmarking
7.2.9.3 Strategic initiatives
7.2.10 West Pharmaceutical Services, Inc.
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Service benchmarking
7.2.10.4 Strategic initiatives
7.2.11 Synecco Ltd.
7.2.11.1 Company overview
7.2.11.2 Service benchmarking
7.2.12 Catalent, Inc.
7.2.12.1 Company overview
7.2.12.2 Financial performance
7.2.12.3 Service benchmarking
7.2.12.4 Strategic initiatives
7.2.13 Thermo Fisher Scientific Inc.
7.2.13.1 Company overview
7.2.13.2 Financial performance
7.2.13.3 Service benchmarking
7.2.13.4 Strategic initiatives
7.2.14 Recipharm AB.
7.2.14.1 Company overview
7.2.14.2 Financial performance
7.2.14.3 Service benchmarking
7.2.14.4 Strategic initiatives
7.2.15 Boehringer Ingelheim International GmbH
7.2.15.1 Company overview
7.2.15.2 Financial performance
7.2.15.3 Service benchmarking
7.2.15.4 Strategic initiatives
7.2.16 Lonza
7.2.16.1 Company overview
7.2.16.2 Financial performance
7.2.16.3 Service benchmarking
7.2.16.4 Strategic initiatives
7.2.17 Samsung Biologics
7.2.17.1 Company overview
7.2.17.2 Financial performance
7.2.17.3 Service benchmarking
7.2.17.4 Strategic initiatives
7.2.18 WuXi AppTec
7.2.18.1 Company overview
7.2.18.2 Financial performance
7.2.18.3 Service benchmarking
7.2.18.4 Strategic initiatives
7.2.19 FUJIFILM Diosynth Biotechnologies
7.2.19.1 Company overview
7.2.19.2 Financial performance
7.2.19.3 Service benchmarking
7.2.19.4 Strategic initiatives
7.2.20 Cambrex Corporation
7.2.20.1 Company overview
7.2.20.2 Financial performance
7.2.20.3 Service benchmarking
7.2.20.4 Strategic initiatives

Chapter 8. KoL Commentary/Recommendations

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
Table 4 North America Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 5 North America Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 6 U.S. Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 7 U.S. Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 8 Canada Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 9 Canada Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 10 Europe Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
Table 11 Europe Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 12 Europe Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 13 UK Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 14 UK Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 15 Germany Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 16 Germany Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 17 France Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 18 France Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 19 Italy Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 20 Italy Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 21 Spain Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 22 Spain Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 23 Denmark Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 24 Denmark Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 25 Sweden Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 26 Sweden Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 27 Norway Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 28 Norway Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 29 Belgium Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 30 Belgium Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 31 Netherlands Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 32 Netherlands Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 36 China Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 37 China Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 38 Japan Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 39 Japan Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 40 India Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 41 India Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 42 Australia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 43 Australia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 44 South Korea Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 45 South Korea Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 46 Philippines Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 47 Philippines Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 48 Malaysia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 49 Malaysia Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 50 Thailand Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 51 Thailand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 52 New Zealand Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 53 New Zealand Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 54 Singapore Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 55 Singapore Healthcare Contract Manufacturing market, by Therapeutic Area, 2018 - 2030 (USD Million)
Table 56 Latin America Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
Table 57 Latin America Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 58 Latin America Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 59 Brazil Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 60 Brazil Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 61 Mexico Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 62 Mexico Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 63 Argentina Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 64 Argentina Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 65 Colombia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 66 Colombia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 67 Chile Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 68 Chile Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 69 Middle East and Africa Healthcare Contract Manufacturing market, by Countries, 2018 - 2030 (USD Million)
Table 70 Middle East and Africa Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 71 Middle East and Africa Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 72 South Africa Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 73 South Africa Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 74 Saudi Arabia Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 75 Saudi Arabia Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 76 UAE Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 77 UAE Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 78 Israel Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 79 Israel Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)
Table 80 Kuwait Healthcare Contract Manufacturing market, by Type, 2018 - 2030 (USD Million)
Table 81 Kuwait Healthcare Contract Manufacturing market, by End use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modelling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Competitive Landscape Snapshot
Fig. 16 Healthcare Contract Manufacturing market segmentation
Fig. 17 Parent market outlook (2022)
Fig. 18 Related/ancillary market outlook (2022)
Fig. 19 Market driver relevance analysis (Current & future impact)
Fig. 20 Current shared End uses and outsourcing usage levels
Fig. 21 Market restraint relevance analysis (Current & future impact)
Fig. 22 Porter’s five forces analysis
Fig. 23 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 24 Healthcare Contract Manufacturing Market Type outlook: Segment dashboard
Fig. 25 Healthcare Contract Manufacturing : Type movement analysis
Fig. 26 Medical devices market, 2018 - 2030 (USD Million)
Fig. 27 Medical devices market, by service, 2018 - 2030 (USD Million)
Fig. 28 Accessories manufacturing market, 2018 - 2030 (USD Million)
Fig. 29 Assembly manufacturing market, 2018 - 2030 (USD Million)
Fig. 30 Component manufacturing market, 2018 - 2030 (USD Million)
Fig. 31 Device manufacturing market, 2018 - 2030 (USD Million)
Fig. 32 Medical devices market, by Therapeutic Area, 2018 - 2030 (USD Million)
Fig. 33 Cardiology market, 2018 - 2030 (USD Million)
Fig. 34 Diagnostic imaging market, 2018 - 2030 (USD Million)
Fig. 35 Orthopedic market, 2018 - 2030 (USD Million)
Fig. 36 IVD market, 2018 - 2030 (USD Million)
Fig. 37 Ophthalmic market, 2018 - 2030 (USD Million)
Fig. 38 General & plastic surgery market, 2018 - 2030 (USD Million)
Fig. 39 Drug delivery market, 2018 - 2030 (USD Million)
Fig. 40 Dental market, 2018 - 2030 (USD Million)
Fig. 41 Endoscopy market, 2018 - 2030 (USD Million)
Fig. 42 Diabetes care market, 2018 - 2030 (USD Million)
Fig. 43 Others market, 2018 - 2030 (USD Million)
Fig. 44 Pharmaceuticals market, 2018 - 2030 (USD Million)
Fig. 45 Pharmaceuticals market, by Service, 2018 - 2030 (USD Million)
Fig. 46 API/Bulk Drugs market, 2018 - 2030 (USD Million)
Fig. 47 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
Fig. 48 Packaging market, 2018 - 2030 (USD Million)
Fig. 49 Finished dose formulation market, 2018 - 2030 (USD Million)
Fig. 50 Finished dose formulation market, by type, 2018 - 2030 (USD Million)
Fig. 51 Solid market, 2018 - 2030 (USD Million)
Fig. 52 Liquid market, 2018 - 2030 (USD Million)
Fig. 53 Semi-solid formulations market, 2018 - 2030 (USD Million)
Fig. 54 Healthcare Contract Manufacturing Market End use outlook: Segment dashboard
Fig. 55 Healthcare Contract Manufacturing : End use movement analysis
Fig. 56 Medical device companies market, 2018 - 2030 (USD Million)
Fig. 57 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 58 Others market, 2018 - 2030 (USD Million)
Fig. 59 Regional marketplace: Segment dashboard
Fig. 60 Regional outlook, 2022 & 2030
Fig. 61 North America market, 2018 - 2030 (USD Million)
Fig. 62 U.S. market, 2018 - 2030 (USD Million)
Fig. 63 Canada market, 2018 - 2030 (USD Million)
Fig. 64 Europe market, 2018 - 2030 (USD Million)
Fig. 65 Germany market, 2018 - 2030 (USD Million)
Fig. 66 UK market, 2018 - 2030 (USD Million)
Fig. 67 France market, 2018 - 2030 (USD Million)
Fig. 68 Italy market, 2018 - 2030 (USD Million)
Fig. 69 Spain market, 2018 - 2030 (USD Million)
Fig. 70 Denmark market, 2018 - 2030(USD Million)
Fig. 71 Sweden market, 2018 - 2030 (USD Million)
Fig. 72 Norway market, 2018 - 2030 (USD Million)
Fig. 73 Belgium market, 2018 - 2030 (USD Million)
Fig. 74 Netherlands market, 2018 - 2030 (USD Million)
Fig. 75 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 76 China market, 2018 - 2030 (USD Million)
Fig. 77 Japan market, 2018 - 2030 (USD Million)
Fig. 78 India market, 2018 - 2030 (USD Million)
Fig. 79 Australia market, 2018 - 2030 (USD Million)
Fig. 80 South Korea market, 2018 - 2030 (USD Million)
Fig. 81 Thailand market, 2018 - 2030 (USD Million)
Fig. 82 Philippines market, 2018 - 2030 (USD Million)
Fig. 83 Malaysia market, 2018 - 2030 (USD Million)
Fig. 84 New Zealand market, 2018 - 2030 (USD Million)
Fig. 85 Singapore market, 2018 - 2030 (USD Million)
Fig. 86 Latin America market, 2018 - 2030 (USD Million)
Fig. 87 Brazil market, 2018 - 2030 (USD Million)
Fig. 88 Mexico market, 2018 - 2030 (USD Million)
Fig. 89 Argentina market, 2018 - 2030 (USD Million)
Fig. 90 Colombia market, 2018 - 2030 (USD Million)
Fig. 91 Chile market, 2018 - 2030 (USD Million)
Fig. 92 Middle East & Africa market, 2018 - 2030 (USD Million)
Fig. 93 South Africa market, 2018 - 2030 (USD Million)
Fig. 94 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 95 UAE market, 2018 - 2030 (USD Million)
Fig. 96 Kuwait market, 2018 - 2030 (USD Million)
Fig. 97 Israel market, 2018 - 2030 (USD Million)